Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 10/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL383476 | 0.82 | ALDH1A1 (0.41) | HSP90AB1HSP90AA1MEN1KMT2ANPC1 | |
| SCHEMBL6765323 | 0.82 | ALDH1A1 (0.50) | HSP90AB1HSP90AA1MEN1KMT2ANPC1 | |
| SCHEMBL8071682 | 0.82 | HSP90AB1 (0.71) | HSP90AB1HSP90AA1ABCB1ADORA2AADORA1 | |
| SCHEMBL3631158 | 0.82 | HSP90AB1 (0.71) | HSP90AB1HSP90AA1ABCB1ADORA2AADORA1 | |
| SCHEMBL164162 | 0.73 | HSP90AB1 (0.54) | HSP90AB1HSP90AA1KMT2ANPC1RAB9A | |
| SCHEMBL10876554 | 0.73 | HSP90AB1 (1.00) | HSP90AB1HSP90AA1MEN1KMT2ANPC1 | |
| SCHEMBL197055 | 0.73 | — | — | |
| SCHEMBL79810 | 0.73 | — | — | |
| SCHEMBL9350626 | 0.71 | HSP90AB1 (0.52) | HSP90AB1HSP90AA1ABCB1ADORA2AADORA1 | |
| SCHEMBL1061788 | 0.70 | HSP90AB1 (0.44) | HSP90AB1HSP90AA1MEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7439340-B2 | For exhaust dyeing, cold batch-up dyeing and continuous dyeing | EVERLIGHT USA, INC. (US) | 2008-10-21 | — | — | US | disclosed |
| US-20080207881-A1 | Reactive dyes containing an alkylthio-s-triazinyl reactive group | EVERLIGHT USA, INC. (US) | 2008-08-28 | — | — | US | disclosed |
| US-20080039614-A1 | Reactive dyes containing an alkylthio-s-triazinyl reactive group | EVERLIGHT USA, INC. (US) | 2008-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207881-A1 | Reactive dyes containing an alkylthio-s-triazinyl reactive group | TST, IK, NOX5 | HSP90AB1 1569/4885HSP90AA1 1956/4885MEN1 4709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.